USPTO serial 79027066
ALBUTHERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 3324843Status 404
- Filing date
- Status date
- Registration date
- Oct 30, 2007
- Examiner
- WILLIAMS, IRENE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALBUTHERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; BIOLOGICAL PRODUCTS, NAMELY, A DRUG DELIVERY SYSTEM COMPRISING ANTIBODIES OR ANTIBODY FRAGMENTS WHICH EXTEND THE EFFECT OF A WIDE VARIETY OF THERAPEUTIC AGENTS, FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; PHARMACEUTICAL PRODUCTS, NAMELY, ALLERGY MEDICATIONS, PAIN MEDICATION, ACNE MEDICATION, ADRENAL HORMONE PREPARATIONS, ANALGESICS, ANAESTHETICS FOR SURGICAL AND NON-SURGICAL USE, ANTACIDS, ANTIARRHYTHMICS, ANTIBACTERIAL PHARMACEUTICALS, ANTIBIOTICS, ANTICOAGULANTS, ANTICONVULSANTS, ANTIDEPRESSANTS, ANTIDIABETIC PREPARATIONS, ANTIEMETICS, ANTIHISTAMINES, ANTIHYPERTENSIVES, ANTIPARASITICS, ANTISEPTICS, ANTITOXIC SERA, ANTIVIRALS, ANTI-ARTHRITIC COMPOSITIONS AND PREPARATIONS, ANTI-CANCER PREPARATIONS, ANTI-COUGH PREPARATIONS, ANTI-DERMOINFECTIVES, ANTI-DIABETIC PHARMACEUTICALS, ANTI-INFECTIVES, ANTI-INFLAMMATORIES, ANTI-SARCOMA PREPARATIONS, ANTI-VENIN, ASPIRIN PREPARATIONS , ANTI- BACTERIAL AND BACTERIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, BETA BLOCKERS, BRONCHIAL DILATORS, BURN RELIEF MEDICATION, CARDIOVASCULAR PHARMACEUTICALS, CENTRAL NERVOUS SYSTEM STIMULANTS, CHEMOTHERAPEUTICS, CHLORAMPHENICOL PREPARATIONS, CHOLESTEROL REDUCERS, CHONDROITIN PREPARATIONS, COLD SORE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, CONTRACEPTIVE PREPARATIONS, COUGH TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, DECONGESTANTS, DERMATOLOGICAL PHARMACEUTICAL PRODUCTS, DIAPHORETICS, DIETARY SUPPLEMENTS, DIURETICS, DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE DELIVERY OF A WIDE RANGE OF PHARMACEUTICALS, EMETICS, EMMENAGOGUES, ERYTHROMYCIN PREPARATIONS, FERTILITY ENHANCEMENT PREPARATIONS, FOOD SUPPLEMENTS, GASTRO-INTESTINAL TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, GERMICIDES, GLAUCOMA AGENTS, HAIR GROWTH STIMULANTS, HEADACHE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HEMORRHOID TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HORMONE PREPARATIONS, HYDROCORTISONE PREPARATIONS, HYPNOTICS, PHARMACEUTICALS FOR TREATMENT AND/OR PROPHYLAXIS OF ANAPHYLACTIC REACTIONS, INSULIN PREPARATIONS, LACTAGOGUES, MEDICAL DIAGNOSTIC REAGENTS, MEDICATED MOUTH CARE AND TREATMENT PREPARATIONS, MEDICATED SKIN HAIR PREPARATIONS, MEDICATED HAIR CARE PREPARATIONS, MIGRAINE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, MIXED ANTIBIOTIC PREPARATIONS, MIXED VITAMIN PREPARATIONS, MOTION SICKNESS TREATMENT PREPARATIONS, MUSCLE RELAXANTS, NAIL FUNGUS TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, NASAL SPRAY PREPARATIONS, NAUSEA TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, OPHTHALMIC PREPARATIONS,OPHTHALMOLOGIC PREPARATIONS, PAIN RELIEF MEDICATION, PANCREAS HORMONE PREPARATIONS, ORAL CONTRACEPTIVES, PARASITICIDES FOR MEDICAL USE, PENICILLIN PREPARATIONS, PHARMACEUTICAL ANTITUSSIVE-COLD PREPARATIONS, PHARMACEUTICAL ANTI-ALLERGIC PREPARATIONS AND SUBSTANCES, PHARMACEUTICALS FOR THE TREATMENT OF ERECTILE DYSFUNCTION, ANTICOAGULANTS, ANTIDEPRESSANTS, APPETITE SUPPRESSANTS, ANTI-OBESITY PREPARATIONS, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF GOUT, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HEART RHYTHM DISORDERS, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF INFECTIOUS DISEASES, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM, PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT AND/OR PROPHYLAXIS OF GASTRO-INTESTINAL DISEASES, PHARMACEUTICAL PREPARATIONS FOR INHALATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF PULMONARY HYPERTENSION, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CHRONIC PULMONARY DISEASE, PHARMACEUTICAL PREPARATIONS FOR OCULAR OR INTRAOCULAR SURGERY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF HORMONAL DISORDERS AND THE PREVENTION OF OSTEOPOROSIS, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF ALLERGIC RHINITIS AND ASTHMA, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF DIABETES, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF SKIN DISORDERS, PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, PHARMACEUTICAL PREPARATIONS FOR WOUNDS, PHARMACEUTICAL PREPARATIONS FOR USE IN UROLOGY, BLOOD CLOTTING AID AND DELIVERY SYSTEMS FOR USE IN HUMAN MEDICINE, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF EYE DISEASES AND CONDITIONS, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR CHLOASMA, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR PREVENTING SKIN BLEMISHES DURING PREGNANCY, PHARMACEUTICAL PRODUCTS FOR OPUTHALMOLOGICAL USE, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF BONE DISEASES, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/OR PROPHYLAXIS OF VIRAL AND INFECTIOUS DISEASES, FOR THE TREATMENT AND/OR PROPHYLAXIS OF CANCER, PHARMACEUTICAL PRODUCTS FOR TREATING AND/OR PROPHYLAXIS OF RESPIRATORY DISEASES AND ASTHMA, LIPID LOWERING AGENTS, PSYCHOTROPICS, PITUITARY HORMONE PREPARATIONS, PREPARATIONS FOR THE SUPPRESSION OF HORMONES, PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF COLDS,RADIATION SICKNESS TREATING AGENTS, SEDATIVES, STEROIDS, MEDICATIONS FOR USE IN WEIGHT REDUCTION PROGRAMMES, STREPTOMYCIN PREPARATIONS, SYNTHETIC NARCOTICS, SYNTHETIC PEPTIDES FOR PHARMACEUTICAL PURPOSES, TETRACYCLINE PREPARATIONS, THIOLUTIN PREPARATIONS, THREONINE PREPARATIONS, TRANQUILISERS, TUMOUR SUPPRESSING AGENTS, VACCINES, PAIN RELIEF MEDICATION, ALL CONTAINING ANTIBODIES OR ANTIBODY FRAGMENTS FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; MEDICAL PREPARATIONS, NAMELY ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS AND ENZYMES FOR TREATMENT OF PAIN, CENTRAL NERVOUS SYSTEM, INFLAMMATORY, RESPIRATORY, NEOPLASTIC, AUTOIMMUNE, INFECTION, NEUROLOGICAL, CARDIOVASCULAR, AND GASTROINTESTINAL DISEASES AND CONDITIONS, AND CANCER | SECTION 71 - CANCELLED | — |
| 042 | RESEARCH AND DEVELOPMENT SERVICES PERFORMED FOR OTHERS IN THE FIELDS OF DRUG DISCOVERY, DRUG DISCOVERY PRODUCTS, PHARMACEUTICALS, MEDICINAL DIAGNOSTICS, AND BIOLOGICAL PRODUCTS; PHARMACEUTICAL AND BIOLOGICAL PRODUCT DEVELOPMENT CONSULTATION; BIOTECHNICAL RESEARCH, CONSULTANCY AND TESTING; LABORATORY RESEARCH AND DEVELOPMENT SERVICES RELATING TO THE PRODUCTION OF ANTIBODIES | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Domantis Limited
- Other trademarks owned by Domantis Limited
- Other trademarks owned by Domantis Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALBUTHERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 10, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 10, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 23, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 23, 2015 | INPC | INVALIDATION PROCESSED | — |
| Feb 6, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 6, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jun 5, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 22, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 4, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 30, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 30, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 17, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 16, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 25, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 23, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2007 | PAPER RECEIVED | — | |
| Oct 13, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 22, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 22, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 14, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |